[ad_1]
Paris, Friday, November 2, 2018 – By giving it an image
glamorous and refined through fashion, advertising, cinema or
television, the tobacco industry has been working to shape a
positive social image of smoking among women. He has
has been shown that, for the same quantity of tobacco consumed, they
have a risk of complications related to this higher addiction
only men.
In this context and on the occasion of the launch of the operation
Month without tobacco, Weekly Epidemiological Bulletin (BEH)
looked at the issue of female smoking.
Female smoking has exploded
Since the 1970s, if, for men, consumption
about 60% of them was almost
halved, in women, smoking has, on the contrary,
exploded to stabilize around 30% until the early years
2000. After a decline, smoking among women
even went up again in the second half of the years
2000, again reaching 30% in 2010.
In addition, other data show that the prevalence of
Smoking during pregnancy remains high and has not experienced any
since 2010. Thus, in 2016, 16.2% of women
pregnant women continued to smoke.
Note, however, that the impressive decline in
observed between 2016 and 2017 (from 13 to 12 million
smokers) seems to have benefited both men and women
although this phenomenon has not yet been fully studied by
the hexagonal epidemiologists.
Myocardial infarction, COPD and lung cancer do not
are more "men's diseases"
Lung cancer, COPD and myocardial infarction have been
long been considered almost pathologies
exclusively male. Now they are among the
main causes of female mortality.
Also, between 2002 and 2012, the standardized incidence rate of
lung cancer globally increased by 72% in women
while he remained stable in men. About the
patients hospitalized for COPD exacerbation, the rate was
doubled among women between 2002 and 2015 when it did not increase
than 30% in men. For myocardial infarction,
observes an increase of more than 50% in the rate of hospitalized women
for myocardial infarction, compared with 16% in men.
Regarding mortality, that of COPD has increased by 3%
among women between 2000 and 2015 when it decreased by 21%
in men and lung cancer increased by 71%
while it decreased by 15% among men.
Unlike the two previous pathologies, mortality
Myocardial infarction remained downward in the
men and women between 2000 and 2015 thanks to the formidable
medical progress achieved in this respect.
In total, if, in 2014, the fraction of deaths attributable to
tobacco was estimated at 20% for men and 7% for men.
women, the percentage of deaths attributable to tobacco among
women has shown a very strong progression since the year 2000,
with an average annual growth rate of 6% between 2000
and 2014 (compared to a decline of 1% per year for
men).
Towards a differentiated treatment according to bad?
Recent studies are showing more and more
clearly, that the addiction to tobacco, physiologically and
psychological, and the management of weaning are different
according to the bad.
Recall, to cite only one, a meta-badysis of 32
studies, published by the reference journal in tabacology
Nicotine & Tobacco Research in March 2017 that was putting in
evidence that in women, varenicline was more effective
that nicotine substitutes, contrary to what is
found in men.
This work concluded that clinicians should
consider varenicillin as the first treatment option
for women In smoking cessation (1).
Other research has focused on studying the impact
cessation campaigns, differentiated according to
bad. They highlighted that it is beneficial to distinguish
messages according to the kind of people they are addressing,
those who foreshadow changes for Operation Month without tobacco
next year …
Frederic Haroche
Source link